Eric F. Kong

1.6k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

Eric F. Kong is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Eric F. Kong has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Eric F. Kong's work include Antifungal resistance and susceptibility (10 papers), Bacterial biofilms and quorum sensing (6 papers) and Fungal Infections and Studies (5 papers). Eric F. Kong is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Bacterial biofilms and quorum sensing (6 papers) and Fungal Infections and Studies (5 papers). Eric F. Kong collaborates with scholars based in United States and Belgium. Eric F. Kong's co-authors include Mary Ann Jabra‐Rizk, Patrick Van Dijck, Soňa Kucharíková, David R. Andes, J. Kristie Johnson, Timothy F. Meiller, Ahmed S. Sultan, Cornelius J. Clancy, Mairi C. Noverr and M. Hong Nguyen and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Eric F. Kong

13 papers receiving 1.2k citations

Hit Papers

Pathogenesis ofCandida albicansbiofilm 2016 2026 2019 2022 2016 100 200 300

Peers

Eric F. Kong
Melphine Harriott United States
Taissa Vila United States
Nihal Bandara United Kingdom
Kaitlin F. Mitchell United States
J. Y. Y. Yau Hong Kong
Elizabeth A. Lilly United States
Michael D. LaFleur United States
Melphine Harriott United States
Eric F. Kong
Citations per year, relative to Eric F. Kong Eric F. Kong (= 1×) peers Melphine Harriott

Countries citing papers authored by Eric F. Kong

Since Specialization
Citations

This map shows the geographic impact of Eric F. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric F. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric F. Kong more than expected).

Fields of papers citing papers by Eric F. Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric F. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric F. Kong. The network helps show where Eric F. Kong may publish in the future.

Co-authorship network of co-authors of Eric F. Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Eric F. Kong. A scholar is included among the top collaborators of Eric F. Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric F. Kong. Eric F. Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kong, Eric F., et al.. (2024). HSV PNEUMONITIS: THE COVID MASQUERADER. CHEST Journal. 166(4). A1078–A1079.
2.
Vila, Taissa, Eric F. Kong, Daniel Montelongo‐Jauregui, et al.. (2021). Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection. Virulence. 12(1). 835–851. 53 indexed citations
3.
Vila, Taissa, Eric F. Kong, Kurt H. Piepenbrink, et al.. (2019). Candida albicans quorum-sensing molecule farnesol modulates staphyloxanthin production and activates the thiol-based oxidative-stress response in Staphylococcus aureus. Virulence. 10(1). 625–642. 37 indexed citations
4.
Sultan, Ahmed S., et al.. (2018). The oral microbiome: A Lesson in coexistence. PLoS Pathogens. 14(1). e1006719–e1006719. 88 indexed citations
5.
Kong, Eric F., et al.. (2017). Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol. Antimicrobial Agents and Chemotherapy. 61(12). 80 indexed citations
6.
7.
Kong, Eric F., J. Kristie Johnson, & Mary Ann Jabra‐Rizk. (2016). Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us. PLoS Pathogens. 12(10). e1005837–e1005837. 87 indexed citations
8.
Jabra‐Rizk, Mary Ann, Eric F. Kong, M. Hong Nguyen, et al.. (2016). Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework. Infection and Immunity. 84(10). 2724–2739. 138 indexed citations
9.
Kong, Eric F., et al.. (2016). Pathogenesis ofCandida albicansbiofilm. Pathogens and Disease. 74(4). ftw018–ftw018. 355 indexed citations breakdown →
10.
Kong, Eric F. & Mary Ann Jabra‐Rizk. (2015). The Great Escape: Pathogen Versus Host. PLoS Pathogens. 11(3). e1004661–e1004661. 12 indexed citations
11.
Khan, Shariq Ali, Eric F. Kong, Timothy F. Meiller, & Mary Ann Jabra‐Rizk. (2015). Periodontal Diseases: Bug Induced, Host Promoted. PLoS Pathogens. 11(7). e1004952–e1004952. 67 indexed citations
12.
Kong, Eric F., et al.. (2015). Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis. Antimicrobial Agents and Chemotherapy. 60(2). 881–889. 46 indexed citations
13.
Kong, Eric F., Mary Ann Jabra‐Rizk, & Paul L. Fidel. (2015). Candida albicans: Love-Hate Relationship with Its Human Host. Microbe Magazine. 10(10). 413–418. 1 indexed citations
14.
Kong, Eric F., Soňa Kucharíková, Patrick Van Dijck, et al.. (2014). Clinical Implications of Oral Candidiasis: Host Tissue Damage and Disseminated Bacterial Disease. Infection and Immunity. 83(2). 604–613. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026